REFERENCES
- Angell, M. (2011a, June 23). Why there is an epidemic of mental illness. New York Review of Books, LVIII(11), 20–22. Retrieved from www.nybooks.com/articles/2011/06/23/epidemic-mental-illness/why/
- Angell, M. (2011b, July 14). The illusion of psychiatry. New York Review of Books, LVIII(12), 20–22. Retrieved from www.nybooks.com/articles/2011/07/14/illusions-of-psychiatry
- Angell, M. (2011c, August 18). The illusion of psychiatry: An exchange. New York Review of Books, LVIII(13), 82–84. Retrieved from www.nybooks.com/articles/2011/08/18/illusions-psychiatry-exchange
- Berk, M., Kapczinski, F., Andreazza, A. C., Dean, O. M., Giorlando, F., Maes, M., & Malhi, G. S. (2011). Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress, and neurotrophic factors. Neuroscience and Biobehavioral Reviews, 35, 804–817. http://dx.doi.org/10.1016/j.neubiorev.2010.10.001
- Bloomfield, P. S., Selvaraj, S., Veronese, M., Rizzo, G., Bertoldo, A., Owen, D. R., & Howes, O. D. (2016). Microglia activity in people at ultra high risk of psychosis and in schizophrenia: An [11C]PBR28 PET brain imaging study. American Journal of Psychiatry, 173(1), 44–52. http://dx.doi.org/10.1176/appi.ajp.2015.14101358
- Champagne, F. A. (2008). Epigenetic mechanisms and the transgenerational effects of maternal care. Frontiers in Neuroendocrinology, 29(3), 386–397. http://dx.doi.org/10.106/j.yfrne.2008.03.003
- Chung, D. W., Fish, K. N., & Lewis, D. A. (2016). Pathological basis for deficient excitatory drive to cortical parvalbumin interneurons in schizophrenia. American Journal of Psychiatry, 173(11), 1131–1139. http://dx.doi.org/10.1176/appi.ajp.2016.16010025
- Clementz, B. A., Sweeney, J. A., Hamm, J. P., Ivleva, E. I., Ethridge, L. W., Pearlson, G. D., & Tamminga, C. A. (2016). Identification of distinct psychosis biotypes using brain-based biomarkers. American Journal of Psychiatry, 173(4). 373–384. http://dxdoi.org/10.1176/appi.ajp.2015.14091200
- Cotel, M. C., Lenartowicz, E. M., Natesan, S., Modo, M. M., Cooper, J. D., Williams, S. C. R., &Vernon, A. C. (2015). Microglia activation in the rat brain following chronic antipsychotic treatment at clinically relevant doses. European Neuropsychopharmacology, 25(11), 2098–107. http://dx.doi.org/10.1016/j.euroneuro.2015.08.004.
- Curlik, D. M., IIII, Maeng, L. Y., Agarwal, P. R., & Shors, T. J. (2012). Physical skill training increases the number of surviving new cells in the adult hippocampus. PLoS One, 8(2), e55850. http://dx.doi.org/10.1371/journal.pone.0055850
- Davidson, R. J. (2000). Affective style, psychopathology, and resilience: Brain mechanisms and plasticity. American Psychologist, 55(11), 1196–1214.
- Davies, J. (2014). Cracked: The unhappy truth about psychiatry. London, UK: Pegasus Books.
- Deacon, B. J. (2013). The biomedical model of mental disorder: A critical analysis of its validity, utility, and effects on psychotherapy research. Clinical Psychology Review, 33(7), 846–861. http://dx.doi.org/10.1016/j.cpr.2012.09.007
- Dettmer, A. M., & Suomi, S. J. (2014). Nonhuman primate models of neuropsychiatric disorders: Influences of early rearing, genetics, and epigenetics. ILAR Journal, 55(2), 361–370. http://dx.doi.org/10.1093/ilar/ilu025
- Dias, B. G., & Ressler, K. J. (2014). Parental olfactory experience influences behavior and neural structure in subsequent generations. Nature Neuroscience, 17(1), 89–96. http://dx.doi.org/10.1038.nn.3594
- DiClemente, C. C. (2007). Mechanisms, determinants, and processes of change in the modification of drinking behavior. Alcoholism: Clinical and Experimental Research, 31(10), 13s–20s. http://dx.doi.org/10.111/j.1530-0277.2007.00489.x
- Dilks, D. D., Julian, J. B., Peli, E., & Kanwisher, N. (2014). Reorganization of visual processing in macular degeneration depends on foveal loss. Optometry and Vision Science, 91(8), e199–e206. http://dx.doi.org/10.1097/OPX.0000000000000325
- Do, K. Q., Cabungcal, J. H., Frank, A., Steullet, P., & Cuenod, M. (2009). Redox dysregulation, neurodevelopment, and schizophrenia. Current Opinions in Neurobiology, 19(2), 220–230. http://dx.doi.org/10.1016/j.conb.2009.05.001
- Eisenberger, N. I., Berkman, E. T., Inagaki, T. K., Rameson, L. T., Mashal, N. M., & Irwin, M. R. (2010). Inflammation-induced anhedonia: Endotoxin reduces ventral striatum responses to reward. Biological Psychiatry, 68(8), 748–754. http://dx.doi.org/10.1016./j.biopsych.2010.06.010
- Eisenberger, N., Inagaki, T. K., Rameson, L. T., Mashal, N. M., & Irwin, M. R. (2009). An fMRI study of cytokine-induced depressed mood and social pain: The role of sex differences. Neuroimage, 47(3), 881–890. http:/dx.doi.org/10.1016/j.neuroimage.2009.04.040
- Frances, A. (2013a). Saving normal: An insider's revolt against out-of-control psychiatric diagnosis, DSM-5, big pharma, and the medicalization of ordinary life. New York, NY: HarperCollins.
- Frances, A. (2013b, June 17). My 12 best tips on psychiatric diagnosis. The Huffington Post. Retrieved from www.huffingtonpost.com/allen-frances/my-12-best-tips-on-psychi_b_3348588.html
- Frankl, V. E. (2000). Man's search for meaning. Boston, MA: Beacon Press.
- Ghaemi, S. N. (2013, July). Requiem for DSM. Psychiatric Times, 17. www.pychiatrictimes.com/dsm-5-0/requiem-dsm.
- Hardingham, G. E., & Do, K. Q. (2016). Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis. Nature Reviews, Neuroscience, 17(2), 125–134. http://dx.doi.org/10.1038.nrn.2015.19
- Harrow, M., & Jobe, T. H. (2013). Does long-term treatment of schizophrenia with antipsychotic medications facilitate recovery? Schizophrenia Bulletin, 39(5), 962–965. http://dx.doi.org/10.1093/schbul/sbt034
- Harrow, M., Jobe, T. H., & Faull, R. N. (2014). Does treatment of schizophrenia with antipsychotic medications eliminate or reduce psychosis? A 20-year multi-follow-up study. Psychological Medicine, 44(14), 3007–3016. https://doi.org/10.1017/S0033291714000610
- Ho, B. C., Andreasen, N. C., Ziebell, S., Pierson, R., & Magnotta, V. (2011). Long-term antipsychotic treatment and brain volumes: A longitudinal study of first-episode schizophrenia. Archives of General Psychiatry, 68(2), 128–137. http://dx.doi.org/10.1001/archgenpsychiatry.2010.199
- Inagaki, T. K., Muscatell, K. A., Irwin, M. R., Cole, S. W., & Eisenberger, N. I. (2012). Inflammation selectively enhances amygdala activity to socially threatening images. Neuroimage, 59(4), 3222–3226. http://dx.doi.org/10.1016/j.neuroimage.2011.10.090
- Insel T. (2013, April 13) NIMH director. Retrieved from http: www.nih.nih.gov/about/director/2013/transforming-diagnosis.shtml. Director's Blog. NIMH Website.
- Insel, T. R. (2015, December 15). Rethinking how we diagnose psychosis. Retrieved from http://blogs.scientificaermican.com/mind-guest-blog/rethining-how-we-diagnose-psychosis
- Johnstone, E. C., Macmillan, J. F., Frith, C. D., Benn, D. K., & Crow, T. J. (1990). Further investigation of the predictors of outcome following first schizophrenic episodes. British Journal of Psychiatry, 157, 182–189. http://dx.doi.org/10.1192/bjp.157.2.182
- Keller, W. R., Kum, L. M., Wehring, H. J., Koola, M. M., Buchanan, R. W., & Kelly, D. L. (2013). A review of anti-inflammatory agents for symptoms of schizophrenia. Journal of Psychopharmacology, 27(4), 337–342. http://dx.doi.org/10.1177/0269881112467089
- Khoury, B., Langer, E. J., & Pagnini, F. (2014). The DSM: Mindful science or mindless power? A critical review. Frontiers in Psychology, 5, Article 602. http://dx.doi.org/10.3389/psyg.2014.00602.
- Kirsch, I. (2010). The emperor's new drugs: Exploding the antidepressant myth. New York, NY: Basic Books.
- Kuswanto, C., Chin, R., Sum, M. Y., Sengupta, S., Fagiolini, A., McIntyre, R. S., & Sim, K. (2016). Shared and divergent neurocognitive impairments in adult patients with schizophrenia and bipolar disorder: Wither the evidence?. Neuroscience and Biobehavioral Reviews, 61, 66–89. http:/dx.doi.org/10.1016/j.neubiorev.2015.12.002
- Lam, D. C., & Salkovskis, P. M. (2007). An experimental investigation of the impact of biological and psychological causal explanations on anxious and depressed patients’ perception of a person with panic disorder. Behavioral Research and Therapy, 45(2), 405–411. http:/dx.doi.org/10.1016/j.brat.2006.03.005
- Lebowitz, M. S. (2014). Biological conceptualizations of mental disorders among affected individuals: A review of correlates and consequences. Clinical Psychology: Science and Practice, 21, 67–83. http://dx.doi.org/10.1111/cpsp.12056
- Lebowitz, M. S., Ahn, W. K., & Nolen-Hoeksema, S. (2013). Fixable or fate? Perceptions of the biology of depression. Journal of Consulting and Clinical Psychology, 81(3), 518–527. http://dx.doi.org/10.1037/a0031730.
- Littrell, J. (2012). Taking the perspective that a depressive state reflects inflammation: Implications for the use of antidepressants. Frontiers in Psychology, 3, 297. http://dx.doi.org/10.3389/fpsyg.2012.00297.
- Littrell, J. (2015). Neuroscience for psychologists and other mental health professionals: Promoting well-being and treating mental illness. New York, NY: Springer.
- Littrell, J. & Magel, D. (1991). The influence of self-concept on change in client behavior. Research in Social Work Practice, 1, 46–67. http://dx.doi.org/101177/104973159100100103
- Martin, D. J., Garske, J. P., & Davis, M. K. (2000). Relation of the therapeutic alliance with outcome and other variables: A meta-analytic review. Journal of Consulting and Clinical Psychology, 68(3), 438–450. http://dx.doi.org/10.1037/0022-006X.68.3.438
- Mayberg, H. (2007, April 21). The subgenual cingulate cortex. Presented at Frontiers in Neuroscience, Emory University, Atlanta.
- Mehta, S., & Farina, A. (1997). Is being “sick” really better? Effect of the disease view of mental disorder on stigma. Journal of Social and Clinical Psychology, 16(4), 405–419.
- Pearlson, G. D. (2015). Etiologic, phenomenologic, and endophenotypic overlap of schizophrenia and bipolar disorder. Annual Review of Clinical Psychology, 11, 231–281. http://dx.doi.org/10.1146/annurev-clinpsy-032814-112915
- Pescosolido, B. A., Martin, J. K., Long, J. S., Medina, T. R., Phelan, J. C., & Link, B. G. (2010). “A disease like any other”: A decade of change in public reactions to schizophrenia, depression, and alcohol dependence. American Journal of Psychiatry, 167, 1321–1330. http://dx.doi.org/10.1176/appi.ajp.2010.09121743.
- Phelan, J. C. (2005). Geneticization of deviant behavior and consequences for stigma: The case of mental illness. Journal of Health and Social Behavior, 46, 307–322. http:/www.jstor.org/stable/4147660
- Porges, S. W. (2011). The polyvagal theory: Neurophysiological foundations of emotions, attachment, communication, and self-regulation. New York, NY: W.W. Norton & Company.
- Roth, T. L., Lubin, F. D., Funk, A. J., & Sweatt, J. D. (2009). Lasting epigenetic influence of early-life adversity on the BDNF gene. Biological Psychiatry, 65(9), 760–769. http://dx.doi.org/10.1016j.biopsych.2008.11.028.
- Schomerus, G., Schwahn, C., Holzinger, A., Corrigan, P. W., Grabe, H. J., Carta, M. H., & Angermeyer, M. C. (2012). Evolution of public attitudes about mental illness: A systemic review and meta-analysis. Acta Psychiatrica Scandanavia, 125, 440–452. http://dx.doi.org/10.1111/j.1600-0447.2012.01826.x
- Shao, W., Zhang, Z., Tang, M., Zhang, X. H., Zhou, Z., Yin, Y. Q., & Zhou, J. W. (2013). Suppression of neuroinflammation by astrocytic dopamine D2 receptor via alphaB-crystallin. Nature, 494(7435), 90–94. http://dx.doi.org/10.1038/nature11748
- Shors, T. J., Anderson, M. I., Curlik, D. M., & Nokia, M. S. (2012). Use it or lose it: How neurogenesis keeps the brain fit for learning. Behavioural Brain Research, 227, 450–458. http://dx.doi.org/10.1016/j.bbr.2011.04.023
- Slavich, G. M., Way, B. M., Eisenberger, N. I., & Taylor, S. E. (2010). Neural sensitivity to social rejection is associated with inflammatory responses to social stress. Proceedings of the National Academy of Sciences, 107(33), 14817–14822. http://dx.doi.org/10.1073/pnas.1009164107
- Sullivan, E. M., & O'Donnell, P. (2012). Inhibitory interneurons, oxidative stress, and schizophrenia. Schizophrenia Bulletin, 38(3), 373–376. http://dx.doi.org/10.1093/schbul/sbs052
- Volk, D. W., Sampson, A. R., Zhang, Y., Edelson, J. R., & Lewis, D. A. (2016). Cortical GABA markers identify a molecular subtype of psychotic and bipolar disorders. Psychological Medicine, 46(12), 2501–2512. http://dx.doi.org/10.1017/S003329176001446
- Weaver, I. C., D'Alessio, A. C., Brown, S. E., Hellstrom, I. C., Dymov, S., Sharma, S., & Meaney, M. J. (2007). The transcription factor nerve growth factor-inducible protein a mediates epigenetic programming: Altering epigenetic marks by immediate-early genes. Journal of Neuroscience, 27(7), 1756–1768. http://dx.doi.org/101523/JNEUROSCI.4164-06.2007
- Whitaker, R. (2010). Anatomy of an epidemic: Magic bullets, psychiatric drugs, and the astonishing risk of mental illness in America. New York, NY: Broadway Books.
- Wunderink, L., Nieboer, R. M., Wiersma, D., Sytema, S., & Nienhuis, F. J. (2013). Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: Long-term follow-up of a 2-year randomized clinical trial. JAMA Psychiatry, 70(9), 913–20. http://dx.doi.org/10.1001/jamapsychiatry.2013.19.
- Zak, P. J., Kurzban, R., & Matzner, W. T. (2004). The neurobiology of trust. Annals of the New York Academy of Sciences, 1032, 224–227. http://dx.doi.org/10.1196/annals.1314.025